Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 220 (RNA5SP220)

Target
RNA5SP220
Molecular classification
Other (Pseudogene, non-coding RNA)
01

Overview

RNA, 5S ribosomal pseudogene 220 (RNA5SP220) is a processed pseudogene related to the 5S ribosomal RNA gene[2]. Unlike 5S rRNA, which is an essential structural and functional component of the large ribosomal subunit in all domains of life[5][7][1], RNA5SP220 has lost its protein-coding capacity due to mutations or loss of regulatory elements, and does not contribute to ribosome structure or function. Pseudogenes may occasionally affect the expression of their parent genes at the RNA level, for example by acting as antisense transcripts or through competition with regulatory factors, but there is no evidence that RNA5SP220 performs any known regulatory or biological function[4]. Pseudogenes are generally not considered therapeutic targets because they do not encode functional proteins or participate directly in canonical signaling, metabolic, or regulatory pathways[4][6][8].

Other names
RN5S220RNA5SP220RNA, 5S ribosomal 220
02

Biological functions

Other (No direct biological function; pseudogenes may sometimes regulate their parent genes via antisense transcripts but typically lack direct function)
03

Disease associations

Other (Some pseudogenes have roles in disease regulation, e.g., via RNA networks or as biomarkers, but there is no specific evidence for RNA5SP220 involvement)

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 220 (RNA5SP220).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 220 (RNA5SP220).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call